Men with Alzheimer's gene at risk of brain bleeding, study finds

Key points
- A common genetic variation, ApoE4, linked to Alzheimer's disease greatly raises the likelihood of tiny brain bleeds in some men, scientists have found.
- Such hemorrhages in brain tissue - microbleeds - leave small points of damage throughout the brain and contribute to memory loss.
- The study led by USC Davis School of Gerontology scientists reveals that the gene variant, ApoE4, has different effects on men and women diagnosed with mild cognitive impairment or Alzheimer's disease.
- The research further underscores the significance of ApoE4 (apolipoprotein E 4) in Alzheimer's, and it builds upon prior studies that indicate the disease has sex-based differences that may affect treatment approaches.
A common genetic variation, ApoE4, linked to Alzheimer's disease greatly raises the likelihood of tiny brain bleeds in some men, scientists have found.
Such hemorrhages in brain tissue - microbleeds - leave small points of damage throughout the brain and contribute to memory loss.
The study led by USC Davis School of Gerontology scientists reveals that the gene variant, ApoE4, has different effects on men and women diagnosed with mild cognitive impairment or Alzheimer's disease.
The research further underscores the significance of ApoE4 (apolipoprotein E 4) in Alzheimer's, and it builds upon prior studies that indicate the disease has sex-based differences that may affect treatment approaches.
"It's important to study sex-based differences in Alzheimer's because women live longer than men, and, as this study shows, the disease can affect them differently," said corresponding author Caleb Finch, University Professor in the USC Davis School of Gerontology and Dornsife College of Letters, Arts, and Sciences.
The finding is especially striking since prior research indicated that Alzheimer's disease was more troublesome for women. Women with ApoE4 are almost twice more likely than men to be diagnosed with the disease. Also, women suffer worse memory loss than men for a given load of plaques and tangles of proteins - the classic Alzheimer's disease markers.
USC studies have found ApoE4 can be an aggravating factor even for non-Alzheimer's patients; ApoE4 is well known for worsening the effects of traumatic brain injury.
The latest study, which involved research on mice and on humans, also provides new evidence that Alzheimer's disease is unique to humans.
"Most diseases can be studied in lab animals without introducing human genes," Finch said. "That is not the case for Alzheimer's."
Even mice and apes that have some factors associated with the disease do not suffer the same cognitive impairments and neuron losses that Alzheimer's patients do, the scientists noted. The likely difference that spares animals from this brain-wasting disease is that animals do not have multiple genetic variants of ApoE - lipid-carrying proteins produced by the liver and by the brain.
Humans have three variants, including ApoE4, the most common Alzheimer's risk gene, while chimpanzees, their closest relative, have only one type of ApoE. The ApoE proteins transport cholesterol and other fats through the bloodstream.
Clinical scientists on Finch's team examined brain scans of 658 subjects, aged 48 to 91 years old, in the United States and Canada, who are part of the Alzheimer's Disease Neuroimaging Initiative. Of those subjects, 402 had mild cognitive impairment, 90 had early-stage Alzheimer's disease, and 166 were cognitively normal.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsAdditive effect of small gene variations can increase risk of autism spectrum disorders
An increased risk of autism spectrum disorders (ASD) could result from an accumulation of many small, common genetic variations rather than large-effect, rare changes in the genetic code, according to a multicenter team…
16 October 2012
NewsA gene implicated in schizophrenia risk is also associated with risk for cannabis dependence
A paper by Shizhong Han and colleagues in the current issue of Biological Psychiatry implicates a new gene in the risk for cannabis dependence. This gene, NRG1, codes for the ErbB4 receptor, a protein implicated in…
12 October 2012
NewsGenentech expands Alzheimer's partnership with AC Immune
Genentech and AC Immune announced a second deal on treatments for Alzheimer's disease Monday. The two companies, which collaborated on crenezumab, which targets beta amyloid proteins, are now taking on Tau proteins,…




